February 17, 2011 -- ScinoPharm announced it will be the sole manufacturer for the active pharmaceutical ingredient of a new anti-depressant, Viibryd. ScinoPharm, a CRO/CMO headquartered in Taiwan, has research facilities in mainland China. The company implied it will make the API at its new GMP plant in Changshu, which is expected to be operational in Q3 of 2011. More details....
